- Report
- March 2024
- 132 Pages
Global
From €865EUR$950USD£734GBP
- Report
- July 2024
- 280 Pages
Global
From €1692EUR$1,859USD£1,437GBP
€2416EUR$2,655USD£2,052GBP
- Report
- July 2021
- 295 Pages
Global
From €2365EUR$2,598USD£2,009GBP
€3379EUR$3,712USD£2,870GBP
- Book
- July 2023
- 304 Pages
The Lateral Flow Assay (LFA) market is a segment of the In Vitro Diagnostics (IVD) industry. It is a rapid, point-of-care diagnostic test that is used to detect the presence of a specific analyte in a sample. LFAs are used in a variety of applications, including clinical diagnostics, food safety, environmental testing, and veterinary diagnostics. LFAs are typically composed of a sample pad, a conjugate pad, a nitrocellulose membrane, and a capture pad. The sample is applied to the sample pad, which then flows through the conjugate pad and the nitrocellulose membrane. The analyte is then captured by the capture pad, which produces a visible signal.
The LFA market is highly competitive, with a number of companies offering products and services. Some of the major players in the market include Abbott, Becton Dickinson, Quidel, Siemens Healthineers, and Roche Diagnostics. Show Less Read more